GPRC5D as a novel immunotherapeutic target in multiple myeloma Editorial


Authors: Nath, K.; Costa, B. A.; Mailankody, S.
Title: GPRC5D as a novel immunotherapeutic target in multiple myeloma
Abstract: The development of modern immune-based therapies for multiple myeloma has expanded rapidly over the past several years, and GPRC5D has been identified as a viable immunotherapeutic target. Herein, we discuss data and provide future perspectives on GPRC5D-directed CAR T cells and bispecific antibodies for patients with relapsed and/or refractory multiple myeloma.
Keywords: car t-cells
Journal Title: Nature Reviews Clinical Oncology
Volume: 20
Issue: 5
ISSN: 1759-4774
Publisher: Nature Publishing Group  
Date Published: 2023-05-01
Start Page: 281
End Page: 282
Language: English
ACCESSION: WOS:000933997300002
DOI: 10.1038/s41571-023-00735-4
PROVIDER: wos
PUBMED: 36725915
Notes: Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karthik Nath
    35 Nath